{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:17:14Z","timestamp":1789881434828,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5870,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.fertnstert.2005.10.031","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T10:44:34Z","timestamp":1144233874000},"page":"1371-1378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes"],"prefix":"10.1016","volume":"85","author":[{"given":"Andrea J.","family":"Rapkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Sogliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Biggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Concas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2005.10.031_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005053-198803000-00003","article-title":"A twin study of the psychiatric side effects of oral contraceptives","volume":"176","author":"Kendler","year":"1988","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(97)00068-1","article-title":"A longitudinal study of birth control, and pregnancy outcome among women in a Swedish population","volume":"56","author":"Larsson","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006842-199909000-00010","article-title":"Gonadal steroids in the treatment of mood disorders","volume":"61","author":"Epperson","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(01)00218-9","article-title":"A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation","volume":"64","author":"Sanders","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-0327(01)00356-1","article-title":"To what extent do oral contraceptives influence mood and affect?","volume":"70","author":"Oinonen","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0306-4530(98)00039-0","article-title":"Behavioral and neurobiological effects of estrogen replacement therapy and a history of triphasic oral contraceptive exposure","volume":"23","author":"Shively","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib7","series-title":"Hormonal contraception","author":"Goldzieher","year":"1994"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1286.007","article-title":"Neurosteroid biosynthesis in the human brain and its clinical implications","volume":"1007","author":"Stoffel-Wagner","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors","volume":"7","author":"Bitran","year":"1995","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0306-4530(02)00064-1","article-title":"Neuroactive steroids","volume":"28","author":"Rupprecht","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(91)90761-J","article-title":"Anxiolytic effect of 3\u03b1-hydroxy-5\u03b1[\u03b2]-pregnan-20-one","volume":"561","author":"Bitran","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1476-5381.1996.tb15476.x","article-title":"Functional correlation between allopregnanolone and [35S]\u2013TBPS binding in the brain of rats exposed to isoniazid, pentylenetrazol or stress","volume":"118","author":"Concas","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0074-7742(01)46065-X","article-title":"Stress and neuroactive steroids","volume":"46","author":"Barbaccia","year":"2001","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/09513590400018223","article-title":"Disadaptive disorders in women","volume":"19","author":"Bernardi","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0301-0082(92)90025-A","article-title":"Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance","volume":"38","author":"Majewska","year":"1992","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(99)00101-1","article-title":"The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat","volume":"106","author":"Akwa","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib20","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluovoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3\u03b1-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-0173(01)00129-1","article-title":"The socially-isolated mouse","volume":"37","author":"Guidotti","year":"2001","journal-title":"Brian Res Brain Res Rev"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1043-2760(01)00503-3","article-title":"Neurosteroids","volume":"13","author":"Mellon","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0361-9230(99)00269-5","article-title":"The specificity of stress responses to different nocuous stimuli","volume":"51","author":"Dubrovsky","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib26","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1210\/jcem.83.9.5081","article-title":"Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients","volume":"83","author":"Heuser","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib27","first-page":"5981","article-title":"Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy","volume":"86","author":"Pearson Murphy","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABAAreceptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment","volume":"159","author":"Str\u00f6hle","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib29","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1023\/A:1026622704704","article-title":"Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder","volume":"25","author":"Bicikova","year":"2000","journal-title":"Neurochem Res"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib30","first-page":"1076","article-title":"Relationship between symptom severity and steroid variation in women with premenstrual syndrome","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","article-title":"Progesterone metabolite allopregnanolone in women with premenstrual syndrome","volume":"90","author":"Rapkin","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09513590310001652955","article-title":"Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome","volume":"18","author":"Lombardi","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00737-002-0147-1","article-title":"GABA receptors, progesterone and premenstrual dysphoric disorder","volume":"6","author":"Sundstrom Poromaa","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1420269","article-title":"Allopregnanolone concentrations and premenstrual syndrome","volume":"142","author":"Monteleone","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/eje.0.1460347","article-title":"Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects","volume":"146","author":"Genazzani","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000026685","article-title":"Electrophysiologic analysis of antidepressant drug effects on the GABA(A) receptor complex based upon antagonist-induced encephalographic power spectrum changes","volume":"42","author":"Matsubara","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib37","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteriodogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/eje.0.1450025","article-title":"Neuroactive steroid-serotonergic interaction","volume":"145","author":"Rasgon","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib39","first-page":"116","article-title":"The human corpus luteum secretes 5 alpha-pregnane-3,20-dione","volume":"111","author":"Backstrom","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib41","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/070674378503000706","article-title":"The clinical diagnosis and classification of premenstrual changes","volume":"30","author":"Halbreich","year":"1985","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib45","series-title":"State Trait Anxiety Inventory, STAI","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib46","series-title":"Profile of mood states","author":"McNair","year":"1971"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0028-3908(01)00187-3","article-title":"Changes in GABAA receptor \u03b32 subunit gene expression induced by long-term administration of oral contraceptives in rats","volume":"42","author":"Follesa","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-3956(00)00006-6","article-title":"Fluoxetine decreases concentrations of 3\u03b1, 5\u03b1-tetrahydrodeoxycorticosterone (THDOC) in major depression","volume":"34","author":"Str\u00f6hle","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib49","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1471-4159.2000.0750732.x","article-title":"Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain","volume":"75","author":"Serra","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/hbeh.2002.1763","article-title":"Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats","volume":"41","author":"Frye","year":"2002","journal-title":"Horm Behav"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.pbb.2004.03.024","article-title":"Hippocampal 3\u03b1, 5\u03b1-THP may alter depressive behavior of pregnant and lactating rats","volume":"78","author":"Frye","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib52","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1073\/pnas.0337642100","article-title":"In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine","volume":"100","author":"Pinna","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psyneuen.2004.07.003","article-title":"Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone","volume":"30","author":"Andr\u00e9en","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib54","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1523\/JNEUROSCI.18-14-05275.1998","article-title":"Withdrawal from 3\u03b1-OH-5\u03b1-pregnan-20-one using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety","volume":"18","author":"Smith","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(99)00232-0","article-title":"Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites","volume":"375","author":"Concas","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib56","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.1073\/pnas.95.22.13284","article-title":"Role of brain allopregnanolone in the plasticity of \u03b3-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery","volume":"95","author":"Concas","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib57","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0026-895X(24)23238-7","article-title":"Allopregnanolone synthesis in cerebellar granule cells","volume":"57","author":"Follesa","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(01)02565-3","article-title":"Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat","volume":"910","author":"Gulinello","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib59","first-page":"57","article-title":"The effects of oral contraceptives on wellbeing and sexuality","volume":"12","author":"Bancroft","year":"1990","journal-title":"Oxford Rev Reprod Biol"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0197-0070(81)80087-3","article-title":"Oral contraceptives and depression","volume":"2","author":"Slap","year":"1981","journal-title":"J Adolesc Health Care"},{"key":"10.1016\/j.fertnstert.2005.10.031_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005053-197209000-00002","article-title":"History of depression as a risk factor for depression with oral contraceptives and discontinuance","volume":"155","author":"Kutner","year":"1972","journal-title":"J Nerv Ment Dis"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:14:21Z","timestamp":1758006861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028206000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0015028206000732"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.10.031","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}